Holen Sie sich die Stockscreener-App
2.19
2.82%
0.06
Handel nachbörslich:
2.16
-0.03
-1.37%
Schlusskurs vom Vortag:
$2.13
Offen:
$2.13
24-Stunden-Volumen:
1.52M
Relative Volume:
0.85
Marktkapitalisierung:
$393.59M
Einnahmen:
$109.16M
Nettoeinkommen (Verlust:
$-9.57M
KGV:
-20.82
EPS:
-0.1052
Netto-Cashflow:
$-104.72M
1W Leistung:
+7.88%
1M Leistung:
-14.45%
6M Leistung:
+294.38%
1J Leistung:
+398.75%
1-Tages-Spanne:
$2.13
$2.30
1-Wochen-Bereich:
$2.03
$2.42
52-Wochen-Spanne:
$0.3418
$3.04
Century Therapeutics Inc Stock (IPSC) Company Profile
Firmenname
Century Therapeutics Inc
Sektor
Branche
Telefon
215-981-4000
Adresse
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Compare IPSC vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
2.19 | 382.81M | 109.16M | -9.57M | -104.72M | -0.1052 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | TD Cowen | Buy |
| 2024-08-08 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-08-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-27 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-10-31 | Eingeleitet | Guggenheim | Buy |
| 2022-10-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-12 | Eingeleitet | William Blair | Mkt Perform |
| 2021-07-13 | Eingeleitet | BofA Securities | Buy |
| 2021-07-13 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-13 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten
Century Therapeutics (NASDAQ: IPSC) CSO has shares withheld for taxes - Stock Titan
IPSC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Options Flow: What are the future prospects of Century Therapeutics IncQuarterly Profit Summary & Smart Money Movement Tracker - baoquankhu1.vn
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Update - MarketBeat
VIX Spike: How does Century Therapeutics Inc perform in inflationary periods2026 Momentum & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Century Therapeutics Updates ATM Program to Enhance Liquidity - TipRanks
Century Therapeutics updates equity offering program with $131.6 million remaining - Investing.com Australia
Century Therapeutics (IPSC) files $150M ATM shelf with TD Cowen - Stock Titan
Century Therapeutics (NASDAQ: IPSC) refreshes shelf and $150,000,000 ATM stock program - Stock Titan
Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference - MSN
According to the latest filing disclosed by the U.S. Securities and Exchange Commission (SEC), biotechnology company Century Therapeutics, Inc. has successfully sold common stock worth $18.4 million through investment bank TD Cowen. - Bitget
Weekly Trades: Is Century Therapeutics Inc in a bullish channel2026 Stock Rankings & Fast Entry Momentum Alerts - baoquankhu1.vn
Downgrade Watch: Will Century Therapeutics Inc benefit from seasonality2026 Dividend Review & Breakout Confirmation Alerts - baoquankhu1.vn
IPSC SEC FilingsCentury Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - stocktitan.net
Century Therapeutics reports 2025 results, advances cell therapy pipeline - MSN
Fed Meeting: Will Arch Capital Group Ltd outperform small cap indexes2026 Buyback Activity & Real-Time Volume Surge Alerts - baoquankhu1.vn
Dip Buying: How sensitive is Century Therapeutics Inc to inflationQuarterly Market Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Century Therapeutics Reports 2025 Results, Advances Cell Therapy Pipeline - MyChesCo
Century Therapeutics Hits New 52-Week High at $2.95 - Markets Mojo
Century Therapeutics Hits New 52-Week High of $3.04 Amid Market Fluctuations - Markets Mojo
Century Therapeutics (NASDAQ:IPSC) Insider Sells $25,693.80 in Stock - MarketBeat
Century Therapeutics (NASDAQ:IPSC) SVP Sells $17,959.65 in Stock - MarketBeat
Century Therapeutics (IPSC) SVP sells 7,043 shares to cover tax withholding - stocktitan.net
Century Therapeutics (IPSC) officer sells shares to cover tax - stocktitan.net
Century Therapeutics, Inc. (NASDAQ:IPSC) Sees Large Growth in Short Interest - MarketBeat
Zacks Research Downgrades Century Therapeutics (NASDAQ:IPSC) to Hold - MarketBeat
Century Therapeutics (IPSC) CEO has 55,397 shares withheld for RSU taxes - Stock Titan
Century Therapeutics (IPSC) CSO has 1,431 shares withheld for RSU tax obligations - Stock Titan
Century Therapeutics (IPSC) Receives a Buy from Clear Street - The Globe and Mail
Century Therapeutics (NASDAQ:IPSC) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Lantheus (LNTH), Century Therapeutics (IPSC) - The Globe and Mail
Century Therapeutics (IPSC) Swings To US$0.51 EPS Profit Challenging Persistent Loss Narratives - simplywall.st
IPSC (NASDAQ: IPSC) plans sale of 10,076 vested shares via Fidelity - Stock Titan
Century Therapeutics, Inc. announced that it has received $134.997458 million in funding from a group of investors - marketscreener.com
Century Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Century Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Century Therapeutics Reports 2025 Results and Pipeline Progress - TipRanks
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates - Investing News Network
CENTURY THERAPEUTICS ($IPSC) Releases Q4 2025 Earnings - Quiver Quantitative
Century Therapeutics 10-K Summary — Revenue: $— | EPS: $— - TradingView
Century Therapeutics 2025 net loss narrows beating estimates - TradingView
Century Therapeutics (NASDAQ: IPSC) slashes 2025 net loss on $109M revenue - Stock Titan
BRIEF-Century Therapeutics FY Net Income USD -9.58 Million - TradingView
Bearish Setup: Is Century Therapeutics Inc undervalued by DCF analysis2026 Catalysts & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Century Therapeutics (IPSC) officer auto-sells shares to cover RSU tax - Stock Titan
Century Therapeutics (IPSC) SVP Carr auto-sells shares to cover RSU tax - Stock Titan
Century Therapeutics (IPSC) to Release Quarterly Earnings on Wednesday - MarketBeat
Century Therapeutics (IPSC) CEO reports 463-share tax withholding on RSU vesting - Stock Titan
[144] Century Therapeutics, Inc. SEC Filing - Stock Titan
Century Therapeutics (NASDAQ:IPSC) Raised to "Hold" at Wall Street Zen - MarketBeat
Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Century Therapeutics Inc-Aktie (IPSC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Russotti Gregory | See Remarks |
Mar 12 '26 |
Sale |
2.55 |
10,076 |
25,684 |
515,427 |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):